INTERNATIONAL PATENT: ANLONG BIOPHARMACEUTICAL CO., LTD., 北京安龙生物医药有限公司 FILES APPLICATION FOR "OLIGONUCLEOTIDE TARGETING COMPLEMENT COMPONENT 3 (C3) GENE AND USE THEREOF"

GENEVA, Aug. 17 -- ANLONG BIOPHARMACEUTICAL CO., LTD. (Room 158, Floor 1, Building 1, Yard 10, Anxiang StreetShunyi District, Beijing 101318), 北京安龙生物医药有限公司 (中国北京市顺义区安祥街10号院1号楼1层158) filed a patent application (PCT/CN2025/076573) for "OLIGONUCLEOTIDE TARGETING COMPLEMENT COMPONENT 3 (C3) GENE AND USE THEREOF" on Feb 09, 2025. With publication no. WO/2025/168134, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which ...